세계의 성형외과수술 및 피부계 시술 시장 규모 : 시술별, 수술 부위별, 용도별, 최종사용자별, 지역 범위별 및 예측

Plastic Surgery And Integumentary System Procedures Market Size And Forecast

Plastic Surgery And Integumentary System Procedures Market size was valued at USD 3.02 Million in 2024 and is projected to reach USD 4.59 Million by 2031, growing at a CAGR of 5.40% during the forecast period 2024-2031.

Some of the key market-driving drivers are rising demand for cosmetic surgery, rising government spending on healthcare and R&D, a sharp rise in cancer cases, rising disposable income, and changes in lifestyle. The Global Plastic Surgery And Integumentary System Procedures Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Plastic Surgery And Integumentary System Procedures Market Definition

Plastic surgery, in its most basic definition, is a treatment used to reconstruct, modify, or repair damaged skin, tissues, or any other bodily component. It can be categorized as either a reconstructive or cosmetic operation. Burns, bruising, and other injuries are treated with reconstructive surgery. On the other hand, cosmetic operations, which are typically performed to improve one's appearance, encompass both invasive and less invasive treatments. It is done for both medicinal and cosmetic purposes. The integumentary system is made up of exocrine glands, hair, nails, and skin. In situations of athlete's foot, skin cancer, acne, etc., a doctor or other specialist will recommend integumentary system surgeries.

In the modern day, these operations are more frequent and widespread. Originally performed only for medical reasons, they have become more popular for cosmetic reasons as well due to changing lifestyles and technological improvements. Many people have started having operations to change their lips, noses, and other physical features in order to feel more confident. Today, a wide variety of operations are offered.

Global Plastic Surgery And Integumentary System Procedures Market Overview

Some of the key market-driving drivers are rising demand for cosmetic surgery, rising government spending on healthcare and R&D, a sharp rise in cancer cases, rising disposable income, and changes in lifestyle. Increased government spending on R&D in the healthcare sector has led to technological advancements. As a result, currently, there are several operations accessible. A sizable portion of the population is increasingly choosing cosmetic treatments like lip fillers or nose surgery. The market is anticipated to grow as a result.

A newer sector of the population may now pay and receive these operations due to an increase in disposable income. Social media usage and media exposure have risen as a result of lifestyle changes. These platforms have an impact on how people see and think. This has caused a change in how people view beauty and what they should appear like. The market is anticipated to expand as a result of this. Obesity and cancer rates have increased as a result of lifestyle changes. Mastectomy surgery, for example, becomes crucial in the management of breast cancer.

Additionally, the rise in obesity cases and the growing impact of social media encourage many people to have liposuction and other fat-removal treatments. The desire to maintain one's youth and attractiveness has also become more popular. As a result, a lot of women have procedures like Botox, eye lifts, etc. The market is anticipated to expand as a result of all these factors.

The expense of surgery, accompanying dangers, and related societal issues are anticipated to impede market expansion. These operations and processes cost a lot of money on their own. In addition, the expenses of maintenance and upkeep may increase due to the need for medications and other supplies. Many people, mostly women, get cosmetic procedures including Botox, cheek lifts, and eye lifts. These operations cannot be reversed. There is no way to repair the harm if these procedures are unsuccessful.

Global Plastic Surgery And Integumentary System Procedures Market Segmentation Analysis

The Global Plastic Surgery And Integumentary System Procedures Market is Segmented on the basis of Procedure, Operating Area, Application, End User, And Geography.

Plastic Surgery And Integumentary System Procedures Market, By Procedure

Prefilled Syringe Biopsy

Excisional Biopsy

Incisional Biopsy

Culture and Sensitivity

Skin Tests

Based on Procedure, the Plastic Surgery And Integumentary System Procedures Market is segmented into Prefilled Syringe Biopsy, Excisional Biopsy, Incisional Biopsy, Culture and Sensitivity, and Skin Tests. The use of a prefilled syringe biopsy, sometimes referred to as a vacuum-assisted biopsy or core biopsy, is a minimally invasive technique for obtaining tissue samples from the body for diagnostic reasons. Common applications include examining suspicious lesions or growths in the breast, liver, lung, prostate, or kidney.

A whole aberrant tissue or lesion, along with a border of healthy tissue, is surgically removed during an excisional biopsy in order to be further examined and diagnosed. When there is a possibility of cancer or another serious condition, this kind of biopsy is frequently carried out. Excisional biopsy may be required to make a conclusive diagnosis when there is a strong suspicion of cancer or other malignant diseases. In these situations, an excisional biopsy enables the full removal of the suspect tissue for further inspection.

Plastic Surgery And Integumentary System Procedures Market, By Operating Area

Eyelids

Subcutaneous Tissue

Breast

Nose

Skin

Based on Operating Area, the Plastic Surgery And Integumentary System Procedures Market is segmented into Eyelids, Subcutaneous Tissue, Breast, Nose, and Skin. The area surrounding the eyelids has undergone more and more plastic surgery treatments in recent years. In operations involving the eyelids, the skin, and tissues around the eyes is the primary focus. The integumentary system includes the skin, hair, nails, and associated glands. Sagging or drooping eyelids are a normal result of the natural decrease of muscle tone and skin flexibility that occurs as the population ages. This could make you look old or worn out. By eliminating extra skin and fat deposits, eyelid operations like blepharoplasty can revitalize the eyelids, giving them a more young and rejuvenated appearance.

Furthermore, operations for breast and integumentary plastic surgery have seen a substantial increase in popularity. These operations are intended to improve the breasts' look, shape, and symmetry. Many people choose breast treatments, including breast augmentation or breast lifts, to improve the shape of their whole body and fulfill their cosmetic objectives. Breast augmentation is the process of enhancing the size and form of the breasts by the use of implants. Breast lift operations restore a more youthful and elevated look by addressing sagging or drooping breasts.

Plastic Surgery And Integumentary System Procedures Market, By Application

Skin Grafts

Allograft

Autograft

Infection

Athlete's Foot

Skin Cancer

Augmentation

Based on Application, the Plastic Surgery And Integumentary System Procedures Market is segmented into Skin Grafts, Allograft, Autograft, Infection, Athlete's Foot, Skin Cancer, and Augmentation. Skin grafting is a surgical operation that replaces missing or damaged skin with healthy skin taken from either a donor or another portion of the patient (autograft or allograft). It is frequently used to heal severe wounds, burns, or regions where the skin has been surgically removed. Skin grafts help the damaged region operate better, recover faster, and look better.

A sort of tissue graft called an allograft is utilized in medical treatments, such as skin grafting. It entails the transplantation of tissue from a donor who is a member of the same species but a distinct person. An allograft is the use of skin tissue from a human donor in the context of skin transplantation. Allografts often use dead donors who gave their consent to tissue donation to provide the donor skin. To guarantee the security and compatibility of the donor tissue, certain regulations and screening processes are followed.

Plastic Surgery And Integumentary System Procedures Market, By End User

Hospitals and Clinics

Research Laboratories

Research Institutes

Based on End User, the Plastic Surgery And Integumentary System Procedures Market is segmented into Hospitals and Clinics, Research Laboratories, and Research Institutes. The demand for integumentary system treatments and plastic surgery is increasing in hospitals and clinics for a variety of reasons. Over time, treatments affecting the integumentary system and plastic surgery have gained societal acceptance and lost some of their stigmas. People are increasingly accepting of the concept of using surgical or non-surgical techniques to improve their looks or address certain issues. The demand for such operations has increased as a result of this change in public attitudes.

Furthermore, plastic surgery and integumentary operations are now safer, more efficient, and need less recovery time because of advancements in surgical methods, tools, and technology. Due to their rapid recovery periods and effective outcomes, minimally invasive procedures including laser therapy, injectables, and non-surgical skin rejuvenation methods have grown in popularity.

Plastic Surgery And Integumentary System Procedures Market, By Geography

North America

Europe

Asia Pacific

Rest of the world

Based on Regional Analysis, the Global Plastic Surgery And Integumentary System Procedures Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Most of the market share is anticipated to come from North America. This can be ascribed to the expanding demand for cosmetic operations, rising government spending on healthcare facilities, shifting consumer lifestyle preferences, and rising R&D spending. Due to similar factors, Europe is anticipated to have the second-largest market share. Due to the area's developing economies, which eventually encourage investment in healthcare and raise disposable income, the Asia Pacific region is predicted to have the biggest growth.

Key Players

The "Global Plastic Surgery And Integumentary System Procedures Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Allergen Inc., CYNOSURE INC., Alma Lasers, Lumenis, Galderma, Merz Pharma, Valeant Pharmaceuticals, Sanofi, Integra Lifesciences, and Scivision Biotech Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Key Developments

• The newest generation of breast implants, PERLETM, has been introduced by GC Aesthetics, Inc. (GCA), a privately held medical technology company that provides aesthetic solutions for international healthcare markets. An industry-leading gel technology (EmunomicTM Breast Tissue Dynamic Gel) from GCA, a proprietary surface technology (BioQTM), and an improved version of the security features that have supported GCA's long-standing excellent safety record define the PERLETM line of smooth breast implants.
• The innovative product line gives surgeons and patients access to an innovative range of smooth implants that benefit from GCA's more than 40 years in the business, its long-standing commitment to patient security and innovation, and its exemplary track record of customer care and support.
• According to Galderma, the FDA has authorized Restylane Defyne for the augmentation and treatment of mild to moderate chin retrusion in mature adults over the age of 21. Online searches for chin augmentation increased by 185% in 2020 alone, contributing to the growing patient demand for a treatment like Restylane Defyne. The first and only chin filler to show outcomes across a wide range of participants, including individuals with various skin types, male subjects, and participants over the age of 52, is Restylane Defyne. Galderma stated that the US FDA had approved RESTYLANE DEFYNE for use in persons over the age of 21 who have mild to moderate chin retrusion.
• Ace Matrix Analysis
• The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.
• Market Attractiveness
• The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Plastic Surgery And Integumentary System Procedures Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.
• Porter's Five Forces
• The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the Global Plastic Surgery And Integumentary System Procedures Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL PLASTIC SURGERY AND INTEGUMENTARY SYSTEM PROCEDURES MARKET

• 1.1 Market Definition
• 1.2 Market Segmentation
• 1.3 Research Timelines
• 1.4 Assumptions
• 1.5 Limitations

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 2.1 Data Mining
• 2.2 Data Triangulation
• 2.3 Bottom-Up Approach
• 2.4 Top-Down Approach
• 2.5 Research Flow
• 2.6 Key Insights from Industry Experts
• 2.7 Data Sources

3 EXECUTIVE SUMMARY

• 3.1 Market Overview
• 3.2 Ecology Mapping
• 3.3 Absolute Market Opportunity
• 3.4 Market Attractiveness
• 3.5 Global Plastic Surgery And Integumentary System Procedures Market Geographical Analysis (CAGR %)
• 3.6 Global Plastic Surgery And Integumentary System Procedures Market, By Procedure (USD Million)
• 3.7 Global Plastic Surgery And Integumentary System Procedures Market, By Operating Area (USD Million)
• 3.8 Global Plastic Surgery And Integumentary System Procedures Market, By Application (USD Million)
• 3.9 Global Plastic Surgery And Integumentary System Procedures Market, By End User (USD Million)
• 3.10 Future Market Opportunities
• 3.11 Global Market Split
• 3.12 Product Life Line

4 GLOBAL PLASTIC SURGERY AND INTEGUMENTARY SYSTEM PROCEDURES MARKET OUTLOOK

• 4.1 Global Plastic Surgery And Integumentary System Procedures Evolution
• 4.2 Drivers
  • 4.2.1 Driver 1
  • 4.2.2 Driver 2
• 4.3 Restraints
  • 4.3.1 Restraint 1
  • 4.3.2 Restraint 2
• 4.4 Opportunities
  • 4.4.1 Opportunity 1
  • 4.4.2 Opportunity 2
• 4.5 Porters Five Force Model
• 4.6 Value Chain Analysis
• 4.7 Pricing Analysis
• 4.8 Macroeconomic Analysis

5 GLOBAL PLASTIC SURGERY AND INTEGUMENTARY SYSTEM PROCEDURES MARKET, BY PROCEDURE

• 5.1 Overview
• 5.2 Prefilled Syringe Biopsy
• 5.3 Excisional Biopsy
• 5.4 Incisional Biopsy
• 5.5 Culture and Sensitivity
• 5.6 Skin Tests

6 GLOBAL PLASTIC SURGERY AND INTEGUMENTARY SYSTEM PROCEDURES MARKET, BY OPERATING AREA

• 6.1 Overview
• 6.2 Eyelids
• 6.3 Subcutaneous Tissue
• 6.4 Breast
• 6.5 Nose
• 6.6 Skin

7 GLOBAL PLASTIC SURGERY AND INTEGUMENTARY SYSTEM PROCEDURES MARKET, BY APPLICATION

• 7.1 Overview
• 7.2 Skin Grafts
• 7.3 Allograft
• 7.4 Autograft
• 7.5 Infection
• 7.6 Athlete's Foot
• 7.7 Skin Cancer
• 7.8 Augmentation

8 GLOBAL PLASTIC SURGERY AND INTEGUMENTARY SYSTEM PROCEDURES MARKET, BY END USE

• 8.1 Overview
• 8.2 Hospitals and Clinics
• 8.3 Research Laboratories
• 8.4 Research Institutes

9 GLOBAL PLASTIC SURGERY AND INTEGUMENTARY SYSTEM PROCEDURES MARKET, BY GEOGRAPHY

• 9.1 Overview
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 U.K.
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Argentina
  • 9.5.3 Rest of Latin America
• 9.6 Middle-East and Africa
  • 9.6.1 UAE
  • 9.6.2 Saudi Arabia
  • 9.6.3 South Africa
  • 9.6.4 Rest of Middle-East and Africa

10 GLOBAL PLASTIC SURGERY AND INTEGUMENTARY SYSTEM PROCEDURES MARKET COMPETITIVE LANDSCAPE

• 10.1 Overview
• 10.2 Company Market Ranking
• 10.3 Key Developments
• 10.4 Company Regional Footprint
• 10.5 Company Industry Footprint
• 10.6 ACE Matrix

11 COMPANY PROFILES

• 11.1 Allergen Inc.
  • 11.1.1 Company Overview
  • 11.1.2 Company Insights
  • 11.1.3 Product Benchmarking
  • 11.1.4 Key Developments
  • 11.1.5 Winning Imperatives
  • 11.1.6 Current Focus & Strategies
  • 11.1.7 Threat from Competition
  • 11.1.8 SWOT Analysis
• 11.2 CYNOSURE INC.
  • 11.2.1 Company Overview
  • 11.2.2 Company Insights
  • 11.2.3 Product Benchmarking
  • 11.2.4 Key Developments
  • 11.2.5 Winning Imperatives
  • 11.2.6 Current Focus & Strategies
  • 11.2.7 Threat from Competition
  • 11.2.8 SWOT Analysis
• 11.3 Alma Lasers
  • 11.3.1 Company Overview
  • 11.3.2 Company Insights
  • 11.3.3 Product Benchmarking
  • 11.3.4 Key Developments
  • 11.3.5 Winning Imperatives
  • 11.3.6 Current Focus & Strategies
  • 11.3.7 Threat from Competition
  • 11.3.8 SWOT Analysis
• 11.4 Lumenis
  • 11.4.1 Company Overview
  • 11.4.2 Company Insights
  • 11.4.3 Product Benchmarking
  • 11.4.4 Key Developments
  • 11.4.5 Winning Imperatives
  • 11.4.6 Current Focus & Strategies
  • 11.4.7 Threat from Competition
  • 11.4.8 SWOT Analysis
• 11.5 Galderma
  • 11.5.1 Company Overview
  • 11.5.2 Company Insights
  • 11.5.3 Product Benchmarking
  • 11.5.4 Key Developments
  • 11.5.5 Winning Imperatives
  • 11.5.6 Current Focus & Strategies
  • 11.5.7 Threat from Competition
  • 11.5.8 SWOT Analysis
• 11.6 Merz Pharma
  • 11.6.1 Company Overview
  • 11.6.2 Company Insights
  • 11.6.3 Product Benchmarking
  • 11.6.4 Key Developments
  • 11.6.5 Winning Imperatives
  • 11.6.6 Current Focus & Strategies
  • 11.6.7 Threat from Competition
  • 11.6.8 SWOT Analysis
• 11.7 Valeant Pharmaceuticals
  • 11.7.1 Company Overview
  • 11.7.2 Company Insights
  • 11.7.3 Product Benchmarking
  • 11.7.4 Key Developments
  • 11.7.5 Winning Imperatives
  • 11.7.6 Current Focus & Strategies
  • 11.7.7 Threat from Competition
  • 11.7.8 SWOT Analysis
• 11.8 Sanofi
  • 11.8.1 Company Overview
  • 11.8.2 Company Insights
  • 11.8.3 Product Benchmarking
  • 11.8.4 Key Developments
  • 11.8.5 Winning Imperatives
  • 11.8.6 Current Focus & Strategies
  • 11.8.7 Threat from Competition
  • 11.8.8 SWOT Analysis
• 11.9 Integra Lifesciences
  • 11.9.1 Company Overview
  • 11.9.2 Company Insights
  • 11.9.3 Product Benchmarking
  • 11.9.4 Key Developments
  • 11.9.5 Winning Imperatives
  • 11.9.6 Current Focus & Strategies
  • 11.9.7 Threat from Competition
  • 11.9.8 SWOT Analysis
• 11.10 Scivision Biotech Inc.
  • 11.10.1 Company Overview
  • 11.10.2 Company Insights
  • 11.10.3 Product Benchmarking
  • 11.10.4 Key Developments
  • 11.10.5 Winning Imperatives
  • 11.10.6 Current Focus & Strategies
  • 11.10.7 Threat from Competition
  • 11.10.8 SWOT Analysis

12 KEY DEVELOPMENTS

• 12.1 Product Launches/Developments
• 12.2 Mergers and Acquisitions
• 12.3 Business Expansions
• 12.4 Partnerships and Collaborations

13 VERIFIED MARKET INTELLIGENCE

• 12.1 About Verified Market Intelligence
• 12.2 Dynamic Data Visualization